Meditech CEO leaves, chair steps down

By Melissa Trudinger
Friday, 30 July, 2004

Meditech (ASX: MTR) is looking for a new CEO as CEO Chris Carter steps down, three months after a shareholder stoush forced his resignation from the company.

The problems arose at Meditech's AGM in late April, where Carter was due to stand for re-election to the board of directors. Slightly more than half of the proxy votes lodged, which represented about 12 per cent of all shareholders, voted against re-election, forcing Carter to withdraw his nomination and hand in his notice of resignation.

The stoush has also resulted in Bob Moses stepping down from his position as chairman of Meditech's board of directors, although he will remain a non-executive director for the time being. Richard Fox, former chairman of the company and a current director will take over as interim chairman.

According to a recent shareholder update from Moses, candidates for CEO are being interviewed at present, and a decision is likely to be announced shortly.

Related News

Cancer drug enters clinical trials based on a false mechanism

A cancer drug currently being tested in patients appears to have entered clinical trials based on...

Russia insists there is "no plague case" following lab worker death

Russian health authorities say there is no evidence that pneumonic plague played a part in the...

Scientists 'reprogram' tumour-supporting immune cells

The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd